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Introduction
Regulated secretion is a fundamental cellular event, which is 
critical to normal physiology. Very many cells release premade 
bioactive proteins from storage organelles in response to exter-
nal stimulation (Burgoyne and Morgan, 2003). The overall 
process of regulated secretion from assembly at the TGN to 
post-Golgi trafficking to final exocytosis and release of granule 
cargo comprises multiple stages. Exocytosis of mature organ-
elles is itself extremely complex and has many different steps 
for an individual organelle (Burgoyne and Morgan, 2003).
A role for actin in the final secretory stages, i.e., in regu-
lated exocytosis, has been studied for several decades with a 
long-recognized history of different outcomes reported in dif-
ferent  cellular  systems  (Cingolani  and  Goda,  2008;  Trifaró   
et al., 2008). Actin has been reported to function in two broad 
ways: to prevent or, paradoxically, to promote exocytosis. One 
of the oldest ideas for a preventative role is that in several cell 
types, actin filaments within the cell cortex (Cramer, 1999a) 
function as a physical barrier to prevent exocytosis (Doreian   
et al., 2008; Berberian et al., 2009; Bittins et al., 2009; Deng   
et al., 2009). Another, not mutually exclusive, view is that in   
endothelial and other cells, a separate population of actin fila-
ment bundles (sometimes termed stress fibers) located within 
the cell cytoplasm (Cramer, 1999a) forms protein–protein struc-
tural links with secretory organelles to directly anchor them 
(Desnos et al., 2003; Waselle et al., 2003; Hume et al., 2007; 
Nightingale et al., 2009), which is a very different role to a 
physical barrier function.
Earlier bodies of work on actin function largely assessed 
regulated secretion at a cell population or tissue level. Rela-
tively recent investigations have imaged actin at the single or 
cluster of granule level (Valentijn et al., 2000b; Sokac et al., 
2003, 2006; Nemoto et al., 2004; Yu and Bement, 2007; Bhat 
and Thorn, 2009; Miklavc et al., 2009). Actin filaments are 
associated with several different types of exocytic organelles, 
mainly appearing as a ring or coat on the organelle membrane 
T
he study of actin in regulated exocytosis has a long 
history with many different results in numerous sys-
tems. A major limitation on identifying precise mecha-
nisms has been the paucity of experimental systems in 
which actin function has been directly assessed alongside 
granule content release at distinct steps of exocytosis of a 
single secretory organelle with sufficient spatiotemporal 
resolution. Using dual-color confocal microscopy and cor-
relative electron microscopy in human endothelial cells, we 
visually distinguished two sequential steps of secretagogue-
stimulated exocytosis: fusion of individual secretory gran-
ules  (Weibel–Palade  bodies  [WPBs])  and  subsequent 
expulsion of von Willebrand factor (VWF) content. Based 
on our observations, we conclude that for fusion, WPBs 
are released from cellular sites of actin anchorage. How-
ever, once fused, a dynamic ring of actin filaments and 
myosin II forms around the granule, and actomyosin II 
contractility squeezes VWF content out into the extra-
cellular environment. This study therefore demonstrates 
how discrete actin cytoskeleton functions within a single 
cellular system explain actin filament–based prevention 
and promotion of specific exocytic steps during regu-
lated secretion.
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Figure 1.  Spinning-disk confocal microscope assay for monitoring fusion of—and VWF release from—individual WPBs in live cells. (A–E) HUVECs were 
nucleofected with the mCherry–P-selectinLum domain and GFP-VWF and imaged with a spinning-disk confocal microscope system in the absence (A) or 
presence (B–E) of 100 ng/ml PMA. Time on the panels indicates total time in media (A), media with PMA (B), or relative to fusion (0 s; C–E). Z stacks were 615 Exocytosis of VWF in endothelial cells • Nightingale et al.
organelle, causing its unique elongated shape (Wagner, 1990; 
Sadler,  2009). At  exocytosis,  the  intraorganellar  pH  of  5.5 
rises to neutrality (Erent et al., 2007b), and the propeptide is 
released, allowing the orderly unfurling of VWF into the flow-
ing plasma as millimeter-long protein strings that act to recruit 
platelets to form a hemostatic plug (Dong et al., 2002). WPB 
cargo also includes the type 1 membrane protein leukocyte re-
ceptor P-selectin (Bonfanti et al., 1989; McEver et al., 1989), 
which is recruited into forming WPBs by the binding of its   
luminal domain to VWF (Michaux et al., 2006b). At exocyto-
sis, P-selectin rapidly diffuses away from the site of organelle 
fusion (Babich et al., 2008), whereas VWF cargo is released 
much more slowly from the same WPB (Babich et al., 2008). 
Thus, these two proteins provide ideal probes for monitoring 
different stages of exocytosis. Furthermore, the low number of 
granules per cell, the large size of the organelles (≤5 µm long), 
and their relatively slow exocytosis together provide an ideal 
opportunity for light microscopy to be used in examining the 
role of actin at different stages of exocytosis by probing single 
secretory organelles.
WPBs are anchored by Rab27A and its effectors to actin 
filament bundles within the cytoplasm (Nightingale et al., 2009) 
to prevent premature exocytosis. We now propose that after   
secretagogue has triggered release from these tethers to allow 
exocytic fusion, a highly dynamic actomyosin II filament ring 
associated with the organelle then functions to expel VWF out-
wards. Thus, actin filaments both prevent and augment the exo-
cytosis of a single regulated secretory organelle.
Results
A two-color assay of different stages of 
the exocytosis of individual WPBs
Different stages of exocytosis of WPBs are easily monitored 
because P-selectin moves away from exocytic sites at fusion, 
whereas  release  of  VWF  into  the  extracellular  environment   
occurs later (Babich et al., 2008). To use P-selectin as a selec-
tive monitor for the early exocytic event of fusion, we expressed 
its soluble luminal WPB-targeting domain tagged with mCherry 
(termed mCherry–P-selectinLum). The removal of transmem-
brane and cytoplasmic domains prevents its reentry into endo-
cytic and recycling routes. This provides a functional readout 
for  fusion  by  monitoring  the  disappearance  of  the  mCherry   
signal. Other markers of fusion (Erent et al., 2007a) that rely on 
specific  behaviors  of  VWF  and  GFP  were  also  used  (see   
paragraph after next for details). To follow postfusion events, 
(Bhat and Thorn, 2009). From these more recent observations, 
both  positive  and  negative  regulations  have  been  inferred,   
involving various mechanistic functions. Actin filament coats 
might prevent exocytosis by slowing down fusion of the organ-
elle with the plasma membrane (Nemoto et al., 2004). In con-
verse, it is envisaged that the coats speed up exocytosis by 
helping the organelle move to the plasma membrane before   
fusion (Valentijn et al., 2000a). Postfusion actin filaments and 
myosin II may work together to maintain an open exocytic pore 
(Larina et al., 2007; Berberian et al., 2009; Bhat and Thorn, 
2009), to provide a contractile force to expel granule content 
(Schietroma et al., 2007; Miklavc et al., 2009), or once cargo 
has been secreted, to retrieve granule membranes during com-
pensatory endocytosis (Sokac et al., 2003, 2006).
Although all of these hypotheses are potentially attrac-
tive, no one experimental system has directly visualized and 
distinguished  the  fusion  event  together  with  the  release  of 
content  step  after  fusion;  in  most  cases,  it  is  only  known 
whether the fusion pore is open, which does not directly report 
cargo release. A similar problem is that actin dynamics have 
not been directly correlated with the exit of cargo from fused 
organelles. Hence, identification of precise actin-based mech-
anisms for fusion and for exit of cargo events after fusion for 
any one system remains difficult. Furthermore, one obvious 
implication of results such as these is that actin might prevent 
exocytosis before fusion yet augment it after fusion within a 
single secretory cell system. This is consistent with work titrat-
ing actin inhibitors (Gasman et al., 2004; Mitchell et al., 2008) 
yet has not yet been explicitly and directly tested within a sin-
gle secretory cell system.
We  wished  to  directly  test  roles  of  actin  for  both  the   
fusion and the release of cargo steps. We have therefore ana-
lyzed actin function at these two discrete steps of exocytosis   
in a single organellar system, monitoring release of endoge-
nous and physiologically relevant cargo. To do this, we chose   
Weibel–Palade bodies (WPBs), the regulated secretory organ-
elles of endothelial cells (Weibel and Palade, 1964; Metcalf   
et al., 2008).
WPBs are involved in the initiation and control of inflam-
matory, hemostatic, angiogenic, and other vascular phenomena 
(Sadler, 2008). Their size and shape are driven by the presence 
of von Willebrand factor (VWF; Wagner et al., 1991; Michaux 
et al., 2006a), a 220-kD glycoprotein that dimerizes in the ER 
and begins to multimerize at the TGN after propeptide cleavage. 
The multimers then bind the propeptide again to rearrange into 
proteinaceous tubules that run parallel to the long axis of the   
acquired at a spacing of 0.5 µm every 5 s for 10 min, and images shown represent maximum intensity projections. (A, unstimulated) mCherry–P-selectinLum 
(Psel.lum.mcherry) and GFP-VWF are colocalized in WPBs, and there is a similar number of WPBs 605 s later. Individual WPBs move within the cytoplasm 
over time. Smaller images show individual channels of the 5-s merged image. (B, PMA stimulated) mCherry–P-selectinLum and GFP-VWF remain colocal-
ized within WPBs by 5 s of PMA stimulation. Smaller images show individual channels of the 5-s merged image. By 605 s, many WPBs have exocytosed 
(asterisks indicate WPBs that fully exocytose during the time course of imaging). (C) Quantification of the intensity of fluorescence of mCherry–P-selectinLum 
and GFP-VWF for the individual organelle shown in D. Note that decrease in mCherry–P-selectinLum fluorescence (5 to 0 s) occurs before the decrease 
in GFP-VWF fluorescence (5 to 25 s) in the same WPB. (D) Still images of a video of exocytosis of the WPB in the box in B. The WPB becomes rounded 
in shape (compare GFP-VWF at 5 and 0 s), and this is linked to loss of mCherry fluorescence intensity (compare 5 and 0 s). (E) Quantification of the 
interval between formation of a rounded GFP-VWF shape and loss of mCherry fluorescence intensity for the population of exocytosing WPBs at 5-s time 
resolution (plotted from 51 events in five cells). (F) Schematic of exocytosis of full-length P-selectin and the P-selectin luminal domain. Bars: (A and B) 10 µm; 
(D) 4 µm.
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Figure 2.  Effect of CCE on WPB exocytosis. (A, B, D, and E) HUVECs coexpressing GFP-VWF and the mCherry–P-selectinLum domain were stimulated with 
100 ng/ml PMA for 10 min with or without a 15-min preincubation with 1 µM CCE (A, B, D, and E) or 0.5 µM jasplakinolide (B). Individual WPB fusion 
events (marked by loss of mCherry–P-selectinLum [P-sel.lum.mcherry] fluorescence) and release of its GFP-VWF contents (marked by loss of GFP fluorescence 617 Exocytosis of VWF in endothelial cells • Nightingale et al.
lag between granule fusion and mean total time to release VWF 
is 21.7 s (70/84), varying between 5 and 70 s for individual   
organelles. For the remaining minority of 14 organelles, 4/14 take 
100–200 s, and 10/14 take 300+ s. Within a single cell, exo-
cytosis is asynchronous; individual WPBs initiate exocytosis at 
any point during 10 min of continuous stimulation, consistent 
with the biochemical measurement of VWF secretion (Michaux 
et al., 2006a). For comparisons of different individual WPBs, 
we normalized the fusion step to 0 s (Fig. 1, C and D). We con-
clude that rapid decrease in mCherry–P-selectinLum fluores-
cence is a faithful readout of the fusion of individual WPBs 
with the plasma membrane, whereas slower loss of GFP-VWF 
fluorescence reflects subsequent release of contents from the 
same individual organelle.
The effect of actin poisons on different 
stages of individual WPB exocytosis
We next treated cells with cytochalasin E (CCE) to inhibit actin 
filament assembly. We chose conditions (15 min with 1 µM 
CCE) to target both stable and dynamic actin structures. Corti-
cal actin filaments and stress fibers with which WPBs are asso-
ciated are relatively stable with a half-life of 10–25 min. This 
CCE treatment causes an 50% reduction in stress fibers in   
human umbilical vein endothelial cells (HUVECs) with no   
detectable change in cell shape or cell adhesion, suggesting   
that there is no major disruption to general cell organization 
(Nightingale et al., 2009).
Consistent  with  actin  filaments  anchoring  granules  in   
endothelial  cells  (Nightingale  et  al.,  2009),  CCE  causes  an   
increase  in  WPB  motility  (Manneville  et  al.,  2003)  and  an   
increase in fusion events (Fig. 2 A), i.e., events in which dis-
appearance of mCherry–P-selectinLum fluorescence and conver-
sion to round-shaped GFP-VWF structures occurred from the 
same double-labeled WPB after secretagogue addition. In stark 
contrast, GFP-VWF release from fused WPBs is blocked within 
CCE-treated cells (Fig. 2, B and compare C and D; and Video 3). 
The duration of release was quantified by determining the interval 
between fusion and complete loss of GFP-VWF signal (Fig. 2 B). 
In  95.3%  (102/107)  of  cases,  the  duration  of VWF  release  is   
>300 s, significantly longer than controls, and most WPBs had 
still not released contents by the end of the video (600 s of film-
ing) or in cases in which we imaged cells for 30 min. We ob-
tained  similar  data  when  assaying  VWF  release  by  ELISA 
(Nightingale et al., 2009). These CCE-treated WPBs cease exo-
cytosis  at  fusion,  as  indicated  by  the  prolonged  duration  of 
round GFP-VWF–positive structures (Fig. 2 D). Stills from low 
VWF internally tagged with GFP (GFP-VWF) provides a 
well-characterized, well-behaved chimera to track the slow 
secretion of the granule core content. Transiently coexpressed 
mCherry–P-selectinLum and GFP-VWF allowed direct ob-
servation of individual WPB exocytosis throughout the whole 
endothelial  cell  using  spinning-disk  confocal  microscopy   
at high temporal and spatial resolution (see Live-cell imag-
ing; Fig. 1).
In  the  absence  of  a  secretagogue,  both  fluorescence 
markers are localized within individual WPBs in cells, and 
the numbers of WPBs do not change with time, though gran-
ules move within the cytoplasm (Fig. 1 A and Video 1). In re-
sponse to the secretagogue (PMA), the proportion of labeled 
WPBs decreases as granules exocytose (Fig. 1 B). The mCherry 
signal is lost first, whereas the GFP-VWF signal initially re-
mains within the same individual organelle (Fig. 1, C and D; 
and Video 2).
The loss of mCherry–P-selectinLum fluorescence in-
tensity correlates with two other fusion-related events. Upon   
fusion, there is a morphological change from a cigar-shaped to 
a more “collapsed,” rounded WPB-shaped structure (Fig. 1 D, 
compare 5 and 0 s), as the rise in pH that occurs upon fusion 
also allows unfurling of the tightly coiled VWF that controls 
WPB shape. Furthermore, there is a transient rapid rise in GFP-
VWF fluorescence intensity (Fig. 1, C and D, 0 s) also caused 
by increased pH upon fusion, correlating with the opening of a 
fusion pore (Erent et al., 2007a). At a 5-s time resolution, rapid 
loss of mCherry fluorescence into bathing medium is tightly 
linked to both these other markers of fusion. For most WPBs, 
mCherry fluorescence disappears at the same time as (0 s) or 
within 5 s of formation of round-shaped WPBs (Fig. 1, D and E) 
and is coincident with the transient rise in brightness of the 
GFP-VWF signal (Fig. 1, C and D, compare 5 and 0 s from 
still images and trace). A minority of WPBs become rounded 
but fail to lose mCherry (10%; Fig. 1 E); these are likely   
undergoing lingering kiss exocytosis whereby a smaller pore 
forms, allowing release of only small cargo content (Babich   
et  al.,  2008).  Such  events  are  excluded  from  our  dataset   
as mCherry–P-selectinLum is too big to exit. At a 5-s time   
resolution, fusion identified with these three markers typically 
takes 0–5 s.
Total release of VWF is often well separated from and 
takes longer than the granule fusion event. We assessed WPB 
fusion (loss of mCherry–P-selectinLum fluorescence) and total 
secretion of VWF (complete loss of GFP-VWF fluorescence) 
with a 5-s temporal resolution. For the majority of events, the 
into the medium) in live cells were assayed as described in Fig. 1. To compare individual WPBs, fusion is assigned to 0 s (see Results for explanation). 
(A) Mean number of individual WPB fusion events in 300 s (n = 11 cells for each condition). Note a more than threefold increase in fusion events in CCE-
treated, PMA-stimulated cells. **, P = 0.004; t test. Error bars show SDs. (B) Duration of release of VWF measured as the lag between WPB fusion and 
full release of GFP-VWF for individual WPBs in live PMA-stimulated cells (83 fusion events in 11 cells) or in PMA-stimulated cells treated with CCE (107 
fusion events in five cells) or jasplakinolide (66 fusion events from six cells). 300+ s indicates that VWF failed to release during 600 s of time-lapse filming.   
(C, control) Still images from a video of individual WPB fusion and release of VWF in live cells. (D, CCE treated) Note that in CCE-treated cells, WPB 
fusion occurs (0 s), yet GFP-VWF fails to release even after 470 s after fusion. (E) Whole-cell view of untreated or CCE-treated, PMA-stimulated live cells. 
Asterisks indicate WPBs that fully exocytose during 300 s of imaging. The boxed regions are the regions shown at higher magnification in C and D at a 
number of time points. Images shown (C–E) represent maximum intensity projections of z stacks. (F) Cells were fixed and labeled for released VWF. Note 
that markedly less VWF strings are apparent in CCE-treated compared with untreated, PMA-stimulated cells. The arrows denote the presence of the strings 
of VWF. Bars: (C and D) 2 µm; (E) 10 µm; (F) 100 µm.
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no effect on WPB fusion (Fig. 6 C), but release of VWF as mea-
sured by ELISA is reduced more than twofold (Fig. 6 D).   
When assessing fusion visually, it is apparent that WPB release   
of VWF is defective; VWF remains within WPBs >95 s after   
fusion (Fig. 6 E) compared with a mean of 21.7 s in untreated cells 
(Fig. 3). Analysis of Lifeact-Ruby by spinning-disk microscopy 
(Fig. 6, E–H) shows that the total lifetime of the actin filament 
ring increases about threefold, ranging from 20 to 60 s (Fig. 6 E-G) 
in blebbistatin-treated cells compared with 10–30 s in controls 
(Fig. 3 D), and the proportion of exocytosing WPBs to which   
actin is recruited is reduced by 1.5-fold (Fig. 6 H compared 
with Fig. 3 A). Thus, for secretion of VWF content, actin fila-
ments (Fig. 2) and myosin II (Fig. 6) are similarly required.
We then wished to analyze in more detail the observed 
myosin II–dependent release of VWF (Fig. 6, D and E) from 
fused WPBs by exploiting the two-color assay (Fig. 1). For our 
experimental system, this would require the use of blue light in 
the presence of blebbistatin. In vitro, blue light blocks blebbi-
statin activity (Sakamoto et al., 2005). However, in cells, the   
effect is unclear; some studies report that activity is similarly 
inhibited (Sakamoto et al., 2005; Charras et al., 2006), whereas 
in other cellular systems, blebbistatin clearly remains active in 
the presence of blue light (Murthy and Wadsworth, 2005). We 
tested the effect of blue light on blebbistatin activity for WPB 
exocytosis and found that, as shown for cytokinesis in epithelial 
cells  (Murthy  and  Wadsworth,  2005),  blebbistatin  remains   
active. We found no difference in the total lifetime of the actin 
filament ring in the presence of blebbistatin with (mean of 38.9 s; 
Fig. S3, A–C) or without (mean of 36.3 s; Fig. 6, E–G) blue 
light compared with blebbistatin-untreated cells (mean of 18.3 s; 
Fig. 3). Similarly, blue light had no detectable effect on the 
blebbistatin-induced  effects  on  actin  recruitment  to  WPBs 
(compare Fig. S3 D [with blue light] and Fig. 6 H [without blue 
light]). We agree with others that the difficulties in effectively 
blocking blebbistatin activity with blue light in cells might re-
flect  constant  diffusion  of  active  drug  into  cells  (Sakamoto   
et al., 2005) or depend on technical differences in imaging or 
cellular systems. Having established that blue light is unlikely a 
concern  for  VWF  exocytosis,  we  assessed  myosin  II–based 
VWF exocytosis (Fig. 6, D and E) in more detail for individual 
granules in the two-color assay (Fig. S3 E). In blebbistatin-
treated cells, in 64% (25/39) of fused granules, VWF release 
fails over the time course of imaging (Fig. S3 E, 300+ s), a time 
that is 10-fold longer than controls (Fig. 3 and Fig. S3 E). For 
the other 36% of fused WPBs, release of VWF is slower or   
similar to controls (Fig. S3 E).
We also blocked myosin II contractility by other methods. 
Specific inhibitors of myosin light chain kinase (Fig. 7, A and 
C–G) or Rho kinase (Fig. 7 B) similar to blebbistatin do not block 
fusion of WPBs (Fig. 7 C) yet do reduce VWF release from 
fused organelles (Fig. 7, A–C), with VWF failing to release from 
70% of individual fused WPBs during 600 s of observation   
(Fig. 7 C). We also noted similar effects on recruitment of actin to 
fused WPBs (Fig. 7 G) and an increase in the total lifetime of the 
actin filament ring that formed (Fig. 7, D–F) in treated cells.   
Although the effect on lifetime in ML-7–treated cells was not as 
marked as that seen with blebbistatin, presumably other regulators 
power videos show that a CCE-treated cell simply accumulates 
a set of interrupted exocytic events (Fig. 2 E), and platelet-
catching VWF strings on the surface of secretagogue-stimulated 
HUVECs are also absent (Fig. 2 F). Pretreating cells with jas-
plakinolide to block actin filament disassembly (Cramer, 1999b) 
similarly blocks release of VWF contents (Fig. 2 B), suggesting 
that  dynamic  actin  filaments  are  required  for  the  late  stage   
of exocytosis.
Actin filaments are rapidly recruited to 
exocytosing WPBs
To support our data suggesting that dynamic actin filaments 
promote the release of VWF, we used Lifeact (Riedl et al., 
2008), an actin filament–binding peptide, coupled to a red or 
green fluorophore to monitor actin filament behavior. Cells co-
transfected with Lifeact plus either mCherry–P-selectinLum or 
GFP-VWF and then stimulated with secretagogue (Fig. 3) show 
that actin ring–type structures are visibly and rapidly recruited 
to 78% of exocytosing WPBs (Fig. 3, A–C; and Video 4). The 
minority of 22% may be below the limit of detection for our 
system. This actin filament ring appears exceptionally dynamic 
with a total lifetime ranging 10–32 s in individual WPBs (Fig. 3 D). 
Careful  analysis  shows  that  actin  ring  formation  usually   
occurs after fusion of WPBs (Fig. 3, B, C, and E–G). In most 
cases (26/39), ring formation and decay (10–32 s; Fig. 3 D) are 
approximately coincident with the timing of total release of 
GFP-VWF (5–49 s; Fig. 2 B, PMA), and the two events are   
often simultaneous or near simultaneous when assayed together 
for an individual fused organelle (Fig. 3, C and G). In a minority 
of  cases  (10/39),  actin  recruitment  cannot  be  temporally   
resolved from fusion (Fig. 3 E), but again, the ring lasts until 
the final release of GFP-VWF. These data are consistent with 
a direct and active role for dynamic actin filaments in the 
later stages of exocytosis of WPBs, i.e., secretion of granule 
core content.
Higher resolution imaging within fixed cells, of three secre-
tory events (Fig. 4, A and B) viewed in xyz sections, shows that 
the actin filaments are located as a ring at or near the bottom of the 
granule (Fig. 4, C and D). Time-lapse microscopy assessing verti-
cal sections during exocytosis of single fused WPBs shows that 
the granule moves relative to the plasma membrane, whereas the 
associated  actin  filament  ring  remains  stationary  toward  the 
plasma membrane distal end of the WPB (Fig. 5 and Video 5), 
consistent with the actin ring driving movement of the fused gran-
ule toward the plasma membrane to effect content extrusion.
Myosin II activity is required for VWF 
release from fused organelles
Nonmuscle myosin II might be involved in exocytosis (Andzelm 
et al., 2007; Doreian et al., 2008; Berberian et al., 2009; Bhat and 
Thorn, 2009), and HUVECs express the IIB isoform (Fig. 6 B). 
We examined the localization of myosin II at exocytosis and 
found that it localized to the actin ring (Fig. 6 A). Both actin fila-
ments (Fig. 3 and Fig. 5) and myosin II (Fig. 6 A) localize to fused 
organelles and are not obviously enriched on WPBs yet to fuse. 
Treating HUVECs with 25 µM ()-blebbistatin (active enantio-
mer), a specific inhibitor of myosin II (Straight et al., 2003), has 619 Exocytosis of VWF in endothelial cells • Nightingale et al.
Figure 3.  Actin is recruited to WPBs during exocytosis. (A–G) HUVECs coexpressing either Lifeact-GFP, a marker for actin filaments, and the mCherry– 
P-selectinLum (P.sel.lum.mcherry) domain (A, B, and D–F) or Lifeact-Ruby and GFP-VWF (C and G) stimulated with 100 ng/ml PMA and imaged live with 
a spinning-disk confocal microscope. Z stacks at a spacing of 0.5 µm were acquired every 2 s (A, B, and D–F) or 5 s (C and G) for 5 min, and images 
are all maximum intensity projections, except Lifeact channels in B and C, which are a single 0.5-µm-deep slices (see Materials and methods for a further 
explanation). Fusion is identified either by loss of mCherry fluorescence (A, D, and E) or by formation of rounded WPB structures (B, C, F, and G; assigned 
to 0 s in D–G). (A) Quantification of WPB fusion events in which Lifeact-GFP was recruited (plotted as the percentage of 143 total fusion events in nine 
cells). (B) Still images from a video that probes an individual WPB fusion event. The asterisk denotes a WPB that does not exocytose in the time course 
shown. (C) Still images from a video that probes an individual WPB fusion event and release of GFP-VWF contents. (D) Lifeact-GFP lifetime on individual 
WPBs (total of 43 WPBs in five cells). Actin filament ring total lifetime is defined as total time to reach peak fluorescence intensity and subsequent decay 
of signal. (E) Lag between WPB fusion and recruitment of Lifeact-GFP (total of 43 WPB fusion events in five cells). Initial actin recruitment is defined as the 
frame relative to fusion in which Lifeact fluorescence is first identified associated with the exocytosing WPB. (F) Change in mean fluorescence intensity of 
mCherry–P-selectinLum and Lifeact-GFP with the times of two WPB fusion events (the granule shown in B is plotted on the left trace). (G) For the WPB shown 
in C, change in mean fluorescence intensity with time of GFP-VWF and Lifeact-Ruby of the fusion and release of VWF content events. The dotted lines show 
the time points of WPB fusion. Bars, 2 µm.JCB • VOLUME 194 • NUMBER 4 • 2011   620
Secretory pores are open in cells treated 
with actin poisons
Is the loss of VWF release caused by a failure to exit through 
the secretory pore or because the secretory pore has closed as 
suggested by Bhat and Thorn (2009)? We used scanning and 
of myosin II activity in addition to myosin light chain kinase are 
involved. Unfortunately, RNAi depletion of myosin II was not 
an effective method because depletion of myosin IIB induced a 
compensatory increase in myosin IIA, and we had little success in 
depleting all isoforms (unpublished data).
Figure 4.  Actin filaments are associated with one end of an individual WPB. (A) Untransfected HUVECs were stimulated for 5 min with 100 ng/ml PMA 
and then fixed in formaldehyde with a procedure optimal for the actin cytoskeleton (see Materials and methods), costained for VWF (red) and phalloidin 
(green), and imaged on a confocal microscope. Images shown are maximum intensity projections. (B) Box region in A is shown at a higher magnification 
and illustrates WPB fusion events associated with actin filament rings. Dotted lines represent regions in which xzy sections were taken. (C and D) Xzy sec-
tions of the zoomed in region showing position of actin filaments relative to VWF. Bars: (A) 10 µm; (C and D) 2 µm.621 Exocytosis of VWF in endothelial cells • Nightingale et al.
gold staining separately). In CCE-treated cells (Fig. 8 B), the 
membrane florets and strings of the VWF protein are not detect-
able, but small clusters of gold-labeled VWF can be seen at the 
plasma membrane, consistent with its exposure via an open   
fusion pore (Fig. 8 B, i–iii).
We performed correlative light microscopy and EM with 
serial sectioning through exocytic structures in secretagogue-
treated HUVECs (Fig. 8, C and D; and Fig. S2). In control cells 
transmission EM (TEM) to investigate the status of the VWF 
and pore in individual CCE-interrupted exocytic events. Scan-
ning EM analysis of the surface of control secretagogue-stimulated 
HUVECs shows (Fig. 8 A) anti-VWF/colloidal gold–tagged 
strings of VWF (Fig. 8 A, i) emerging from structures com-
prised of membrane florets (Fig. 8 A, ii and iii), which is pre-
sumably a consequence of WPB fusion and/or the movement 
(Fig. 5) of fused WPBs (see Fig. S1 for images showing VWF 
Figure 5.  Fused WPBs translocate out of the plane of the plasma membrane during WPB release of contents. (A) Still from an xyz-projected view of WPB 
exocytosis. Inset shows the region in which the vertical (yz projection) was made in B. Time is relative to fusion (0 s). The dotted line shows the part of the cell 
in which a yz section was generated. The boxed region is shown at higher magnification and at a number of time points in B. Bar, 10 µm. (B) Time series 
of the organelle in the box in A as viewed in a vertical section. The short red arrows (0–55 s; GFP-VWF and Lifeact-Ruby time strips) indicate the position 
of the center of maximum fluorescence intensity within the WPBs or associated actin filaments at the point of fusion (0 s), and the long white arrows show 
the center at each new position (5–55 s). The WPB appears to translocate to the right. Actin filaments associated with WPBs appear to remain stationary 
with respect to the substratum. VWF and Lifeact-Ruby are single image planes. Bar, 1 µm.JCB • VOLUME 194 • NUMBER 4 • 2011   622
Figure 6.  Myosin II activity is required for the release of VWF contents. (A) Untransfected HUVECs were stimulated for 5 min with 100 ng/ml PMA and 
then fixed in formaldehyde with a procedure optimal for imaging the actin cytoskeleton and myosin II (see Materials and methods), costained for pan–myosin II 
(panMyoII; blue), VWF (red), and actin (green), and imaged on a confocal microscope. The magnified insets on the right show an exocytosing WPB with 623 Exocytosis of VWF in endothelial cells • Nightingale et al.
A physical barrier would prevent exocytosis of both immature 
and mature granules equally, whereas anchoring to actin fila-
ments might allow a degree of discriminatory regulation.
An actomyosin II filament ring associates 
with exocytosing WPBs to expel VWF cargo
After secretagogue stimulation, we demonstrated an additional 
actin-dependent function in supporting the release of the granule 
core protein VWF (Fig. 2 and Fig. 3). After WPB fusion with 
the plasma membrane, actin filaments are recruited to form a 
transient ring around/under the WPB (Fig. 3, Fig. 4, and Fig. 5). 
Actin  filaments  are  also  recruited  to  other  fused  organelles 
(Valentijn  et  al.,  2000b;  Sokac  et  al.,  2003;  Miklavc  et  al., 
2009). In all these situations, the actin serves to coat the organ-
elle rather than forming the ring-like structure we noted at WPB 
exocytosis (Fig. 4).
Several functions have been proposed for actin filaments 
recruited  to  exocytic  organelles  after  fusion  in  other  cells   
(see Introduction for details; Segawa and Yamashina, 1989;   
Valentijn et al., 2000b; Sokac et al., 2003; Nemoto et al., 2004; 
Schietroma et al., 2007; Bhat and Thorn, 2009). However, in 
these  studies,  endogenous  cargo  release  was  not  probed,  or 
cargo and actin were not visualized directly together with an 
appropriate temporal resolution to allow identification of ex-
actly when actin could act with respect to cargo release. Our 
new data directly correlate with high precision the release of 
endogenous cargo with the time at which actin functions.
These data lead us to a model in which an actin filament 
ring acts as a minicytokinetic ring to exert force on the bottom 
of an open granule, helping to push VWF out of the other end 
into the extracellular environment. First, the appearance, dura-
tion, and disappearance of the actin filament ring approximately 
mirrors the initiation and continued release of VWF cargo   
(Fig. 3 and Fig. 5). Second, we have localized myosin II at the 
actin ring during exocytosis (Fig. 6 A). Third, we know from our 
temporal analysis of fusion and content release in live HUVECs 
that myosin II ATPase is required at the same step as the actin 
ring to release VWF cargo from organelles after they have fused 
(Fig. 6 and Fig. 7). Critically, actin ring dynamic behavior is 
also tightly linked to the 600-nm movement of fused WPBs 
relative to the plasma membrane, which in turn, correlates with 
VWF release from that same WPB (Fig. 5). Furthermore, to 
extrude content in this way requires that actin filament ring 
(Fig.  8  C),  500-nm-wide  open  pores  are  seen  with  VWF   
labeled with colloidal gold exiting. This exiting VWF extends 
from  the  pore  to  well  above  the  plasma  membrane  (e.g.,   
Fig. 8 C, v). In CCE-treated cells (Fig. 8 D), similar fusion 
pores are also clearly open. However, in contrast to controls, 
VWF fails to extend much beyond the open pore site (e.g.,   
Fig. 8 D, v). This is even more apparent when the serial EM   
images are reconstructed into a single 3D image (Fig. 8, C and D, 
vi; and Videos 6 and 7). These data show that although the fu-
sion pore is open (Fig. 8, A and C), VWF does not release (Fig. 2 
and Fig. 8, B and D) in CCE-treated cells.
Discussion
In this paper, we assay both the fusion and content release stages 
of exocytosis alongside actin function, directly detecting and 
monitoring individual organelles by light microscopy and con-
firming key aspects by correlative EM. We have visualized sin-
gle organelles at sufficient spatial and temporal resolution to 
monitor fusion of WPBs with the plasma membrane and subse-
quent release of VWF cargo independently.
Actin filaments initially prevent fusion  
of WPBs
We found that actin filaments initially act to inhibit secretion. 
The increase in the number of fused WPBs after drug-induced 
actin filament depolymerization (Fig. 2) is consistent with pub-
lished data suggesting that WPBs are anchored via a ternary 
complex, including Rab27A/MyRIP (Nightingale et al., 2009), 
to the actin cytoskeleton to prevent premature fusion. A granule 
anchorage function for actin filaments has been proposed for 
several secretory cell types (Desnos et al., 2003; Waselle et al., 
2003; Hume et al., 2007). The other inhibitory role postulated   
is that of a cortical actin barrier on exocytosis. We cannot com-
pletely rule out an inhibitory barrier function for cortical actin, 
but the close agreement between the extent of VWF release 
seen in Rab27a knockdown cells (Nightingale et al., 2009) and 
the increase in the number of fusion events documented here 
argues that, in endothelial cells at least, it plays a relatively   
minor role. Anchoring of granules to actin filaments may be 
particularly important in endothelial cells, in which there is a 
necessity for only mature granules to fuse, to maintain clini-
cally essential levels of multimerization within VWF in plasma. 
an actin ring and a WPB in a similar part of the cell yet to exocytose with no actin ring. Images shown are maximum intensity projections. The arrows 
highlight the recruitment of actin and myosin to the exocytosing VWF in the first three images. But in a situation in which VWF is not released (the next 
three images), actin and myosin are not recruited. Bar, 10 µm. (B) Western blot analysis of myosin II isotypes in HUVECs. (C) HUVECs expressing the 
mCherry–P-selectinLum domain were stimulated with 100 ng/ml PMA for 10 min with or without a 5-min preincubation with 25 µM blebbistatin. Mean 
number of individual WPB fusion events in 300 s (control: n = 11 cells; blebbistatin: n = 6 cells; **, P = 0.004; ns, P = 0.863; t test). Error bars show 
SDs. (D) Quantification of VWF secretion at different blebbistatin concentrations. Error bars represent SDs. (E–H) HUVECs coexpressing VWF-GFP and 
Lifeact-Ruby were imaged before treatment with blebbistatin, preincubated with 25 µM blebbistatin for 2 min, and then stimulated with 100 ng/ml PMA for 
10 min (in the continued presence of blebbistatin). During blebbistatin treatment, time-lapse images were only acquired from the Lifeact-Ruby (i.e., no blue 
light was present). A final image was then acquired from both markers. (E) Still images from a video of individual WPB fusion and blebbistatin-inhibited 
release of VWF in live cells. Bar, 2 µm. (F) Actin filament ring total lifetime, defined as total time to reach peak fluorescence intensity and subsequent decay 
of signal, in blebbistatin-treated cells (plotted from 39 actin-positive fusion events in six cells). (G) Quantification of intensity of fluorescence of Lifeact-Ruby 
for the individual organelle shown in E. The dotted line shows the time point of WPB fusion. (H) Quantification of WPB fusion events in which Lifeact-Ruby 
was recruited (plotted as the percentage of 82 total fusion events in six cells) to WPBs in the presence of blebbistatin. Note that blocking myosin II has no 
effect on the fusion of WPBs yet blocks subsequent secretion of VWF from the same fused organelle and extends the lifetime of the actin filament ring. In all 
parts of this figure, blebbistatin treatment of cells was performed in the absence of any blue light, except for the final image in E (labeled post).
 JCB • VOLUME 194 • NUMBER 4 • 2011   624
Figure 7.  Myosin light chain kinase activity is required for the release of VWF contents. (A–G) HUVECs coexpressing GFP-VWF and the mCherry– 
P-selectinLum domain were stimulated with 100 ng/ml PMA for 10 min with or without a 15-min preincubation with 50 µM ML-7 (A and C–G) or treated 
with Y27632 (B). Fusion is assigned to 0 s. (A) Quantification of VWF secretion at different ML-7 concentrations. (B) Quantification of VWF secretion at 625 Exocytosis of VWF in endothelial cells • Nightingale et al.
nucleated and assembled on the surface of the organelle. In PC12 
cells, Arp2/3 is localized to secretory granules and likely nucle-
ates actin filaments on these granules in these cells (Gasman et al., 
2004), and in cortical granules, neural Wiskott-Aldrich Syndrome 
protein and cdc42 have shown to be necessary for coat forma-
tion (Sokac et al., 2003). However, knockdown of Arp3 has no 
effect on regulated release of VWF, and Arp3 is not localized to 
WPBs (unpublished data). Thus, actin filament formation on 
granules may be regulated differently in different cells.
The WPB actin ring is exceptionally dynamic, completely 
forming and disassembling within a mean of 20 s. Actin fila-
ment coats on other regulated secretory organelles vary in sta-
bility,  with  actin  recruitment  in  cortical  granules  appearing 
similarly dynamic (Sokac et al., 2003) but actin recruitment on 
lamellar  bodies  appearing  markedly  slower  (Miklavc  et  al., 
2009). Outside of secretory organelles, highly dynamic actin 
filaments, e.g., within leading edge protrusions in motile cells, 
turn over with a half-life of 1–3 min, much slower than the 
WPB actin ring. Inhibition of actin filament disassembly (Fig. 2) or 
myosin II activity (Fig. 6) both significantly extend the duration 
of the WPB actin filament ring. Thus, although the myosin II 
force is not required to form the actin ring, actomyosin II con-
tractility may augment actin filament ring depolymerization. 
Certainly, myosin II–dependent actin filament turnover occurs 
within dividing (Guha et al., 2005; Murthy and Wadsworth, 
2005) and in motile cells (Vallotton et al., 2004; Medeiros et al., 
2006; Wilson et al., 2010).
The extent to which actin filament force-based extru-
sion of cargo is a general mode of action for cells other than   
HUVECs remains to be directly determined. That actin fila-
ments have been identified on both small and large granules in 
several cell types is perhaps indicative of wide-ranging impor-
tance. In the endothelial cell, a large amount of protein content 
must be secreted into the lumen of the blood vessel to quickly 
recruit platelets. It is also possible that, for this reason, a special 
mode of secretion had to be adopted, and perhaps, secretion of 
surfactant from lung cells (Miklavc et al., 2009) with its unique 
hydrophobic properties may present a similar burden on the 
exocytic machinery. We would argue that only by distinguish-
ing and imaging exocytosis at both fusion and release of cargo 
steps directly alongside the analysis of actin dynamics during 
exocytosis can prefusion actin-dependent anchoring be sepa-
rated from the postfusion augmentation of content release.
Materials and methods
Cell culture and nucleofection
HUVECs were cultured as described previously (Michaux et al., 2006a). 
GFP-VWF (Romani de Wit et al., 2003) was a gift from J. Voorberg and 
J.A. Van Mourik (Sanquin Research Laboratory, Amsterdam, Netherlands). 
position is polarized toward the distal end of the granule as ob-
served (Fig. 5 and Fig. 6). This model is also consistent with the 
failure of VWF to move out of open pores (Fig. 8 B) or to form 
strings (Fig. 2) when cells are treated with an inhibitor of actin 
assembly. Mathematical modeling also suggests that contractile 
force can be driven via polymer disassembly (Mogilner and 
Oster, 2003), which is not inconsistent with some of our data 
(Fig. 2 and Fig. 3) and may contribute to actomyosin II–based 
force. The actin-dependent movement of VWF out of fused 
granules may also underlie the notable membrane florets that 
form at the exocytic site (Fig. 8 A), as such structures are absent 
in the scanning EM of CCE-treated cells. In vivo, the intravascular 
blood flow would also help to unfurl VWF into platelet-catching 
strings connected to the surface of endothelial cells.
Other potential roles for myosin II for 
exocytosing granules
In other situations, actomyosin II contractility is instead thought 
to hold open the pore at exocytosis (Larina et al., 2007; Bhat 
and Thorn, 2009). We have little evidence for this function in 
VWF secretion: analysis of pore structure after exocytosis in 
the presence of an actin-depolymerizing agent shows multiple 
arrested open pores, and more pores are noted than in untreated 
cells (Fig. 2 E and Fig. 8). The pore size appears similar in gross 
size to those of untreated cells (500 nm), but we did note 
pieces of membrane that partially obscured parts of the pore. 
We regard these as pieces of membrane that would ordinarily 
be pushed from the mouth of the pore at exocytosis. Given the 
observed large size of the WPB fusion pore, we cannot view 
these flaps as likely to impede release of VWF. Furthermore, 
the observed position of the actin filament ring toward the base 
of the WPB (Fig. 4) means, conceptually, it is less likely to sta-
bilize the fusion pore/keep the pore open, as it is not directly 
present at the plasma membrane.
In Xenopus laevis oocytes, actomyosin II associated with 
fused granules is thought to drive a later process—compression 
of  granule  membrane  during  compensatory  endocytosis  that   
occurs after cargo has been released. We do not have a direct 
measure of the timing of any reendocytosis of WPBs in endo-
thelial cells and cannot rule out such a possibility. However,   
F-actin rings around exocytosing WPBs disappear around the 
time that the last of the VWF is released, implying that the ring 
in endothelial cells may not persist long enough to also be in-
volved in reendocytosis in these cells.
Mechanism of assembly and turnover of 
the F-actin ring associated with WPBs
We did not detect any actin filament translocation toward the 
WPB membrane, suggesting that actin filaments are directly 
different Y27632 concentrations. (C) Lag between WPB fusion and full release of GFP-VWF for individual WPBs in live PMA-stimulated cells in the presence 
(137 fusion events in nine cells) or absence (83 fusion events in 11 cells) of ML-7. 300+ s indicates that VWF failed to release during 600 s of time-lapse 
filming. (D) Still images from a video of an individual WPB fusion event in ML-7–inhibited cells cotransfected with mCherry–P-selectinLum (P.sel.lum.mcherry) 
and Lifeact-GFP. Bar, 2 µm. (E) Actin filament ring total lifetime, defined as total time to reach peak fluorescence intensity and subsequent decay of signal, 
in ML-7–treated cells (plotted from 63 actin positive fusion events from six cells). (F) Quantification of intensity of fluorescence of mCherry–P-selectinLum and 
Lifeact-GFP for the individual organelle shown in D. The dotted line shows the time point of WPB fusion. (G) Quantification of WPB fusion events in which 
Lifeact-GFP was recruited (plotted as the percentage of 142 total fusion events in six cells) to WPBs in the presence of ML-7. Error bars represent SDs.
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Figure 8.  Ultrastructural analysis of WPBs during exocytosis. (A–D) HUVECs were stimulated with 100 ng/ml PMA for 10 min (A and C) or pretreated 
with 1 µM CCE for 15 min before PMA stimulation (B and D) and then labeled for released VWF (15-nm gold [A and B] or 15-nm gold and Alexa Fluor 
488 nm [C and D]). (A) Scanning EM of PMA-stimulated HUVECs shows a network of VWF strings (i) and marked membrane ruffling (ii and iii) that appear 627 Exocytosis of VWF in endothelial cells • Nightingale et al.
analyzed  at  450  nm  in  a  thermomax  microplate  reader  (Molecular   
Devices) using a kinetic protocol with a reading every 30 s for 30 min. 
Basal and stimulated releases were presented as a percentage of total 
VWF present in the cells (basal releasate + stimulated releasate + remainder 
present in the lysate).
Live-cell imaging
Nucleofected cells were plated in 4-well coverglass chamber slides (Thermo 
Fisher Scientific) and imaged in a heat-controlled chamber at 37°C in   
HUVEC growth media. The cells were pretreated with or without the rele-
vant drugs, 25 µM blebbistatin (2 min), 1 µM CCE (15 min), or 50 µM ML-7 
(15 min), before stimulating with 100 ng/ml PMA (while maintaining the 
appropriate drug concentration). Cells were visualized using a 100× oil   
immersion lens (NA 1.4) on an spinning-disk system (UltraVIEW VoX; Perkin-
Elmer) mounted on an inverted microscope (TiE; Nikon) with an EM charge-
coupled  device  camera  (512  ×  512  pixels;  C9100-13;  Hamamatsu 
Photonics) and 488- and 561-nm solid-state lasers. Z stacks were acquired 
using a piezo (NanoScanZ; Prior Scientific) every 2–5 s for 5–10-min peri-
ods with a step size of 0.4–0.5 µm, comprising 9–14 pictures (depending 
on cell height) with an exposure for each image at 30 ms. Images were   
analyzed, and maximum intensity and yz projections were generated in 
Volocity (version 5.3.1; PerkinElmer). In Fig. 3 and Fig. 6, single image 
planes from a z stack are shown to illustrate the actin filament ring that 
forms at the bottom of WPBs, whereas maximum intensity projections of the 
entire stack are used to illustrate the WPB. This is the optimal way of dis-
playing all of the information during exocytosis; WPBs are larger (1–5 µm) 
than a single image plane (0.5 µm) and, thus, capturing the entire WPB 
structure requires several planes. In addition, this will also capture VWF, as 
it starts to diffuse away from fused WPBs. Actin filament rings associated 
with WPBs are only 0.5–1 µm and, thus, are captured in only 1–2 image 
planes. In addition, there is an abundance of other actin filament structures 
in other image planes that are not associated with fused WPBs, e.g., stress 
fibers and any maximum intensity projection would portray these irrelevant 
actin filament structures from other spatial locations.
Quantification of exocytosis videos
Loss of mCherry–P-selectinLum was used mainly as a marker of fusion, as 
this reports only the fusion step. However, to compare GFP-VWF release of 
contents with actin filament behavior (Fig. 3, Fig. 4, Fig. 5, and Fig. 6), we 
instead chose rounded WPB shape or transient increase in GFP-VWF as 
markers of fusion. The lag between fusion and total VWF release was de-
fined as the time between loss of P-selectinLum–mCherry to the loss of GFP-
VWF fluorescence at the exocytic site. Data are displayed as a frequency 
distribution of all exocytic events from several cells, and therefore, error 
bars are not appropriate.
Volocity (version 5.3.1) was used to determine mean fluorescence 
intensity of the transfected proteins during exocytosis. In both analysis pro-
tocols, quantification was performed on maximum intensity projections. In 
situations in which we needed to determine the integrated mean fluores-
cent intensity of two WPB-specific fluorescent probes during the process of 
exocytosis (Fig. 1), we defined the relevant region by intensity (1.478 for 
the 488-nm line and 0.919 for the 561-nm line). We then used a fine me-
dian filter to remove the background and excluded any regions <0.05 µm
3. 
The  mean  fluorescent  intensity  was  then  determined  for  the  defined   
region. A same-size region outside the cell was used to determine a back-
ground fluorescence at each of the time points and was subtracted to give 
the final intensity values.
When imaging the exocytosis of a fluorescent protein in relation to 
actin (Fig. 3 and Fig. 6), we determined the mean fluorescence intensity 
across a region of interest defined as the minimal region that comprised both 
the WPB and actin ring fluorescence. A same-size region outside the cell 
was used to determine a background fluorescence at each of the time points, 
and this was subtracted to give the final intensity values. Mean fluorescence 
The C terminal–tagged P-selectinLum–mCherry fusion construct was generated 
by  amplification  from  a  P-selectin  luminal  PRK5  construct  (Harrison-Lavoie   
et al., 2006) using primers encoding flanking 5 BglII and 3 SmaI sites. 
The product was digested with BglII and SmaI and ligated into pmCherry 
N1 vector (Takara Bio Inc.) digested with BglII and EcoRV. Lifeact-GFP 
(Riedl et al., 2008) and Lifeact-Ruby were gifts from B. Baum (University 
College London, London, England, UK). DNA (typically 1–5 µg) was trans-
fected into HUVECs by nucleofection using the program U-001 (Lonza). 
Cells were typically assayed 24 h after transfection.
Antibodies for immunofluorescence
Rabbit anti-VWF (1 in 10,000) was purchased from Dako. Sheep anti-
VWF (1 in 10,000) was purchased from AbD Serotec. Rabbit anti–myosin 
IIA, –myosin IIB, and –myosin IIC (1 in 200) were purchased from Cell Sig-
naling Technology. Rabbit pan–myosin II (1 in 50) was obtained from Bio-
genesis. Mouse antiactin (clone C4; 1 in 200) was purchased from MP 
Biomedicals. Alexa Fluor 488- and 568-nm fluorescent conjugates (1 in 
500) and Alexa Fluor 488-nm conjugated phalloidin were obtained from 
Invitrogen. Cy5 fluorescent conjugates (1 in 200) were purchased from 
Jackson ImmunoResearch Laboratories, Inc.
Immunofluorescence
For standard fixation, cells were fixed at 37°C in 4% methanol-free formal-
dehyde (TAAB Laboratories Equipment, Ltd.) in cytoskeleton buffer (10 mM 
MES, pH 6.1, 3 mM MgCl2, 138 mM KCl, and 2 mM EGTA) with 0.32 M 
sucrose and then permeabilized in 0.5% Triton X-100 and incubated with 
Alexa Fluor 488–conjugated phalloidin (Invitrogen) and a relevant primary 
antibody. For myosin II staining, cells were fixed in cytoskeleton buffer with 
0.32 M sucrose and 4% methanol-free formaldehyde supplemented with 
0.1% Triton X-100 and 2 µg/ml phalloidin. Cells were then postfixed in 
methanol at 20°C for 3 min and incubated with the relevant primary   
antibodies. The cells were then rinsed, and a 488-nm, 568-nm, or Cy5 sec-
ondary antibody was added before mounting with antifade reagent con-
taining DAPI (ProLong; Invitrogen). This method optimally preserves the 
cytoskeleton  (Cramer  and  Mitchison,  1993).  Mounted  coverslips  were   
imaged  at  an  ambient  temperature  through  a  63×  oil  immersion  lens   
(NA 1.3) on a confocal system (TCS SPE; Leica).
Western blotting
Proteins were separated by SDS-PAGE, transferred to Whatman nitrocellu-
lose membranes (PerkinElmer), and then probed with the following antibodies: 
rabbit anti–myosin IIA, –myosin IIB, and –myosin IIC (1 in 1,000); mouse 
antitubulin antibodies (1 in 500) purchased from Sigma-Aldrich; and rabbit 
anti-VWF (1 in 500). Then, nitrocellulose membranes were incubated with the 
appropriate anti–rabbit or –mouse HRP-conjugated secondary antibodies 
(1 in 5,000) purchased from Jackson ImmunoResearch Laboratories, Inc.
Secretion assay and ELISA
HUVECs were incubated with 1 µM CCE, 0–25 µM blebbistatin, 0–100 µM 
Y27632, or 0–100 µM ML-7 (Sigma-Aldrich) for 5–15 min before de-
termining VWF release. The VWF secretion assay has been described pre-
viously (Lui-Roberts et al., 2005). In short, cells were rinsed and incubated 
in serum-free medium in the presence or absence of 100 ng/ml PMA 
(Sigma-Aldrich) and/or the relevant drug for 30 min. The medium was col-
lected, and the remaining cells were then lysed to determine total VWF levels. 
Relative amounts of VWF were determined by ELISA (Blagoveshchenskaya 
et al., 2002). MaxiSorp plates (Thermo Fisher Scientific) were coated with 
the rabbit anti-VWF antibody (Dako) and blocked before addition of the 
basal, stimulated, and lysate samples alongside serially diluted human 
plasma as a VWF standard. Plates were washed, and a rabbit anti-VWF 
antibody conjugated to HRP was added (Dako). After further rounds of 
washing, the plate was developed with o-phenylenediamine dihydrochlo-
ride and hydrogen peroxide in a citrate phosphate buffer. Absorbance was 
to be sites of WPB exocytosis and initial VWF string release. These strings and sites are extensively labeled with anti-VWF/gold (see Fig. S1 for backscatter 
images showing VWF gold labeling). (B, i) CCE-treated cells show a marked absence of VWF strings. Instead, only small patches of intense gold labeling 
are present with no membrane ruffling, indicating the WPBs have fused but failed to release VWF as strings. (ii and iii) Magnified regions of the areas 
described by the white boxes. (C and D, i) Differential interference contrast images overlayed with a fluorescent image of VWF labeling (green). A specific 
exocytic site is magnified in the white boxed region. (C and D, ii–v) Serial TEM sections of the exocytic site shown in C and D (i) with v being the highest 
section. (C and D, vi) 3D reconstruction of the serial sections shown above. The reconstructions are also shown as Videos 6 and 7, revealing the same 
exocytic structures from a variety of angles. For the reconstruction, the VWF is highlighted in green, whereas the remainder of the cell is purple. Note that 
the VWF is released normally in the untreated cell, whereas the VWF in the drug-treated cell appears to be incompletely exocytosed. Fluorescent images are 
maximum intensity projections. All the serial TEM sections are shown in Fig. S2. Bars: (A and B, i–iii) 1 µm; (C and D, i) 10 µm; (C and D, ii–v) 200 nm.
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values  obtained  therefore  represent  the  mean  fluorescence  across  the 
whole region of interest. WPB-specific probes will therefore have a lower 
fluorescence intensity than for the protocol used in Fig. 1.
Correlative light and TEM
HUVECs  were  plated  into  gridded  coverslip–bottomed  dishes  (MatTek) 
and, 24 h later, pretreated for 15 min with or without 1 µM CCE followed 
by stimulation with 100 ng/ml PMA for 10 min. Cells were fixed and 
stained with rabbit anti-VWF followed by labeling with both an Alexa Fluor 
488-nm secondary antibody and protein A–gold (15 nm). Cells were then 
imaged in 0.1 M cacodylate using a 20× air (NA 0.7), 40× oil (NA 1.25), 
and 63× oil (NA 1.4) immersion objectives on a confocal microscope 
(SP5; Leica) at an ambient temperature. Fluorescent z stacks and differen-
tial interference contrast images were acquired to identify the same cell by 
TEM. The coverslips were fixed in EM-grade 2% paraformaldehyde, 2% 
glutaraldehyde (TAAB Laboratories Equipment, Ltd.) secondarily fixed in 
1% osmium tetraoxide, and 1.5% potassium ferricyanide and then tannic 
acid treated. Samples were then dehydrated and embedded in Epon resin. 
Coverslips were inverted onto prepolymerized Epon stubs and polymer-
ized by baking at 60°C overnight. The cells of interest were found on   
the block surface by using the grid marks transferred from the coverslip, 
and the light microscopy images and serial 70-nm-thin sections were cut 
with a diatome 45° diamond knife using an ultramicrotome (UC7; Leica).   
Ribbons of sections were collected on 1 × 2–mm Formvar-coated slot grids 
and  stained  with  Reynolds  lead  citrate.  Samples  were  imaged  using   
a transmission electron microscope (Tecnai G2 Spirit; FEI) and a charge-
coupled  device  camera  (SIS  Morada;  Olympus).  The  serial  sections   
were aligned and reconstructed into a 3D projection using Amira 5.2.2   
software (Visage).
Scanning EM
HUVECs were grown on glass coverslips and treated as for TEM until   
dehydration. The samples were then critically point dried using a point 
drying apparatus (Polaron E3100; Quorum Technologies, Ltd.) mounted 
onto 12.5-mm-diam aluminum stubs using electrodag (silver DAG; Agar 
Scientific)  and  coated  with  a  2–3-nm-thick  layer  of  carbon  using  an   
ion beam coater (Gatan, Inc.). Samples were examined at 5.0 kV on   
a  high-resolution  field  emission-scanning  electron  microscope  (JSM-
7401F; JEOL).
Online supplemental material
Fig. S1 shows scanning EM secondary electron images of VWF strings at 
exocytosis alongside backscattered electron images that show VWF gold 
labeling. Fig. S2 shows all serial TEM sections used for the 3D reconstruc-
tions shown in Fig. 8 (C and D, vi). Fig. S3 shows the effect of blebbistatin 
treatment on actin ring recruitment, lifetime, and VWF exocytosis while   
imaging with blue light. Video 1 shows an unstimulated HUVEC trans-
fected with GFP-VWF and mCherry–P-selectinLum domain as visualized by 
spinning-disk confocal microscopy over a 10-min period. Video 2 shows 
a  PMA-stimulated  HUVEC  transfected  with  GFP-VWF  and  mCherry–P- 
selectinLum domain as visualized by spinning-disk confocal microscopy over   
a 10-min period. Video 3 shows a HUVEC transfected with GFP-VWF and 
mCherry–P-selectinLum domain after pretreatment with CCE and stimula-
tion with PMA as visualized by spinning-disk confocal microscopy over a 
10-min period. Video 4 shows a HUVEC transfected with Lifeact-GFP and 
mCherry–P-selectinLum domain after stimulation with PMA as visualized by 
spinning-disk confocal microscopy over a 5-min period. Video 5 shows a 
yz slice of a HUVEC transfected with Lifeact-Ruby and GFP-VWF exocyto-
sing after stimulation with PMA as visualized by spinning-disk confocal   
microscopy. Video 6 shows an animation of the 3D reconstruction shown in 
Fig. 8 C (vi). Video 7 shows an animation of the 3D reconstruction shown 
in Fig. 8 D (vi). Online supplemental material is available at http://www 
.jcb.org/cgi/content/full/jcb.201011119/DC1.
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